Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 EP1083 | DOI: 10.1530/endoabs.110.EP1083

ECEESPE2025 ePoster Presentations Pituitary, Neuroendocrinology and Puberty (220 abstracts)

MRI findings in girls with central precocious puberty: a comparative study with control group and their association with pubertal diagnosis and progression

Victor Cugi Gonçalves 1 , Angelo Chelotti Duarte 2 , Ana Luiza Padua Aratangy Pontes 3 , Carlos Alberto Longui 1,3 , Antônio José da Rocha 2 & Cristiane Kochi 1,3


1Irmandade da Santa Casa de Misericórdia de São Paulo, Unidade de Endocrinologia Pediátrica, São Paulo, Brazil; 2Irmandade da Santa Casa de Misericórdia de São Paulo, Departamento de Radiologia, São Paulo, Brazil; 3Santa Casa de São Paulo, Faculdade de Ciências Médicas, São Paulo, Brazil


JOINT853

Context: Central precocious puberty (CPP) has a complex etiology that involves a variety of conditions. Although approximately 90% of cases in girls are classified as idiopathic, a subset presents additional imaging findings that may have clinical significance.

Objective: To compare the frequency of brain magnetic resonance imaging (MRI) findings between girls with CPP and a control group and analyze, in CPP patients, their relationship with pubertal diagnosis and progression.

Methods: Data were collected between April 2017 and November 2024 from 102 girls who exhibited clinical pubertal progression before the age of 8 and underwent brain MRI, as well as 25 girls and 72 boys with other conditions, the majority diagnosed with idiopathic short stature, who also underwent brain MRI. The data evaluated were chronological age (CA), height SDS (zH), body mass index SDS (zBMI), bone age (BA), LH levels at diagnosis and after follow-up.

Results: Abnormal MRI findings were observed in 38 girls (37.3%) from the CPP group and in 19 individuals (19.6%) from the control group (z test, P <0.05). Among the 38 abnormalities in the CPP group, 33 (32.4%) where classified as indeterminate (I) (e.g., inter-hypothalamic adhesion, pars intermedia cyst, pineal gland cyst), while 5 (4.9%) were classified as pathologic lesions (PL) (e.g., hypothalamic-optochiasmatic glioma, hydrocephalus). In the control group, all 19 abnormalities were limited to I, with no cases of PL. Girls with CPP due to PL exhibited a shorter interval between the diagnosis and the start of pubertal suppression therapy (P = 0.017) and showed less advanced bone age relative to chronological age at diagnosis (P = 0.035). No significant differences were found among the CPP subgroups in terms of age at puberty onset, age at diagnosis, BA at diagnosis, bone age-corrected height SDS, baseline LH, LH peak after GnRH stimulation, CA at initiation and discontinuation of pubertal suppression therapy, or age at menarche.

Conclusions: It is essential to perform MRI on all girls with CPP, including those aged 6-8 years, since they may also have undiagnosed PL. There were no differences in CPP group patients with or without abnormal MRI findings in relation to clinical or laboratory data. While indeterminate findings are more frequent in girls with CPP compared to the control group, these cannot yet be established as a cause or indicative of a different progression of puberty.

Key words: precocious puberty; MRI; glioma; inter-hypothalamic adhesion.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches